Search results
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
Pharmaceutical Technology via Yahoo Finance· 25 minutes agoNovartis has released positive data from the Phase III ASC4FIRST trial showing that its tyrosine...
Ballentine Partners LLC Increases Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 1 day agoBallentine Partners LLC boosted its position in Novartis AG (NYSE:NVS – Free Report) by 13.2% in the 1st quarter, according to its most recent filing with the Securities and ...
Here's Why Novartis (NVS) is a Strong Value Stock
Zacks via Yahoo Finance· 23 hours agoUtilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks. ...
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
BioPharma Dive via Yahoo Finance· 8 hours agoThe Boston-based company is debuting with $82 million from a group of investors that include ...
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
Clinical Trials Arena via Yahoo Finance· 26 minutes agoThe company’s money woes started last year when it stopped development work on its gene therapy...
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s...
Digital Journal· 5 days ago...Published June 20, 2024 ACCESSWIRE PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo...
Three Swiss Dividend Stocks Offering Up To 5.4% Yield
Simply Wall St. via Yahoo Finance· 9 hours agoThe Switzerland market recently demonstrated resilience, gaining strength amid optimism for...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance· 6 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 4 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 5 days agoSome popular names in the pharma sector are Pfizer PFE, Johnson & Johnson JNJ, Novo Nordisk NVO,...